NO20006269L - Tetrahydronaftyridinyl-karboksamider med anti-konvulsiv aktivitet - Google Patents

Tetrahydronaftyridinyl-karboksamider med anti-konvulsiv aktivitet

Info

Publication number
NO20006269L
NO20006269L NO20006269A NO20006269A NO20006269L NO 20006269 L NO20006269 L NO 20006269L NO 20006269 A NO20006269 A NO 20006269A NO 20006269 A NO20006269 A NO 20006269A NO 20006269 L NO20006269 L NO 20006269L
Authority
NO
Norway
Prior art keywords
tetrahydronaphthyridinyl
carboxamides
convulsive activity
convulsive
activity
Prior art date
Application number
NO20006269A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006269D0 (no
Inventor
John David Harling
Frank Peter Harrington
Mervyn Thompson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20006269D0 publication Critical patent/NO20006269D0/no
Publication of NO20006269L publication Critical patent/NO20006269L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • AIDS & HIV (AREA)
  • Anesthesiology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20006269A 1998-06-12 2000-12-11 Tetrahydronaftyridinyl-karboksamider med anti-konvulsiv aktivitet NO20006269L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812683.2A GB9812683D0 (en) 1998-06-12 1998-06-12 Novel compounds
PCT/GB1999/001826 WO1999065903A1 (en) 1998-06-12 1999-06-09 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity

Publications (2)

Publication Number Publication Date
NO20006269D0 NO20006269D0 (no) 2000-12-11
NO20006269L true NO20006269L (no) 2001-02-07

Family

ID=10833636

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006269A NO20006269L (no) 1998-06-12 2000-12-11 Tetrahydronaftyridinyl-karboksamider med anti-konvulsiv aktivitet

Country Status (31)

Country Link
US (2) US6410555B1 (id)
EP (1) EP1084122B1 (id)
JP (1) JP2002518390A (id)
KR (1) KR20010052792A (id)
CN (1) CN1311789A (id)
AP (1) AP2000002009A0 (id)
AR (1) AR018656A1 (id)
AT (1) ATE252579T1 (id)
AU (1) AU750470B2 (id)
BG (1) BG105126A (id)
BR (1) BR9911110A (id)
CA (1) CA2334900A1 (id)
CO (1) CO5040081A1 (id)
CZ (1) CZ293010B6 (id)
DE (1) DE69912278T2 (id)
EA (1) EA200100033A1 (id)
ES (1) ES2209524T3 (id)
GB (1) GB9812683D0 (id)
HU (1) HUP0102773A3 (id)
ID (1) ID27593A (id)
IL (1) IL140171A0 (id)
MA (1) MA26646A1 (id)
NO (1) NO20006269L (id)
NZ (1) NZ508799A (id)
PE (1) PE20000727A1 (id)
PL (1) PL344791A1 (id)
SK (1) SK18962000A3 (id)
TR (1) TR200003694T2 (id)
TW (1) TW495510B (id)
WO (1) WO1999065903A1 (id)
ZA (1) ZA200007397B (id)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds
EP1243263B1 (en) * 2001-03-21 2002-11-27 Schwarz Pharma Ag Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
CA2624625A1 (en) * 2005-11-04 2007-05-10 Pfizer Limited Tetrahydronaphthyridine derivative
JP6378182B2 (ja) * 2012-08-27 2018-08-22 アレイ バイオファーマ、インコーポレイテッド 過剰増殖性│疾患の処置のためのセリン／スレオニンキナーゼ阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
CZ416498A3 (cs) 1996-06-17 1999-06-16 Smithkline Beecham Plc Substituovaný benzamidový derivát a jeho použití jako antikonvulsantu
GB9711257D0 (en) * 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
DE69912278T2 (de) 2004-08-12
DE69912278D1 (en) 2003-11-27
ATE252579T1 (de) 2003-11-15
AP2000002009A0 (en) 2000-12-31
WO1999065903A1 (en) 1999-12-23
CA2334900A1 (en) 1999-12-23
SK18962000A3 (sk) 2001-08-06
US6762192B2 (en) 2004-07-13
TW495510B (en) 2002-07-21
ID27593A (id) 2001-04-12
NZ508799A (en) 2003-08-29
PE20000727A1 (es) 2000-09-28
EP1084122A1 (en) 2001-03-21
US20020143029A1 (en) 2002-10-03
NO20006269D0 (no) 2000-12-11
AR018656A1 (es) 2001-11-28
EP1084122B1 (en) 2003-10-22
BR9911110A (pt) 2001-10-30
KR20010052792A (ko) 2001-06-25
MA26646A1 (fr) 2004-12-20
AU4280099A (en) 2000-01-05
CZ20004611A3 (en) 2001-06-13
ZA200007397B (en) 2002-02-27
JP2002518390A (ja) 2002-06-25
IL140171A0 (en) 2002-02-10
AU750470B2 (en) 2002-07-18
CN1311789A (zh) 2001-09-05
HUP0102773A3 (en) 2002-09-30
CZ293010B6 (cs) 2004-01-14
PL344791A1 (en) 2001-11-19
TR200003694T2 (tr) 2001-06-21
HUP0102773A2 (hu) 2002-01-28
GB9812683D0 (en) 1998-08-12
ES2209524T3 (es) 2004-06-16
EA200100033A1 (ru) 2001-06-25
BG105126A (en) 2001-11-30
CO5040081A1 (es) 2001-05-29
US6410555B1 (en) 2002-06-25

Similar Documents

Publication Publication Date Title
NO305319B1 (no) Forbindelser med antifungal aktivitet
NO20003137D0 (no) Nye bispidinforbindelser med antiarytmisk aktivitet
NO971471D0 (no) Nye karboksamider med fungicid aktivitet
IS5699A (is) Ný notkun
TR199501420A2 (tr) Acillenmis ensülin benzerleri.
FI953303L (fi) Uusi fytaasi
DK1025241T3 (da) Protease-varianter med mangfoldige substitutioner
ID20837A (id) Mikrokapsul dengan laju pelepasan yang mudah disesuaikan
DE59711798D1 (de) Gestrick
FI972194L (fi) Uusia bentsyylipyrimidiinejä
MX210210B (es) Nuevos catalizadores
IS5379A (is) Efnasambönd með taugafrumuvirkni
FI953710L (fi) Uusia pyrrolokarbatsoleja
PT1036083E (pt) Novos 9a-azalidos
ID17169A (id) Untaian ritsleting rajutan
ID17167A (id) Untaian ritsleting rajutan
DK0983266T3 (da) Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
NO20006269L (no) Tetrahydronaftyridinyl-karboksamider med anti-konvulsiv aktivitet
PT1102769E (pt) Carboxamidas triciclicas
DE69702094D1 (de) N-Acetonylbenzamidverbindungen mit fungizider Aktivität
DK1019042T3 (da) Forbindelser med anti-første-passagevirkning
EP0717286A3 (en) Consumption meter
PT1102746E (pt) Fenilamidinas substituidas com accao antitrombotica
FI973961A0 (fi) Lyft- och belastningsanordning foer en valsstapel i en kalander
KR960018626U (ko) 무선 프로그램 장치

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application